Article Information
History
- September 28, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Joachim Linssen1,
- Anthony Ermens2,
- Marvin Berrevoets3,
- Michela Seghezzi4,
- Giulia Previtali4,
- Simone van der Sar-van der Brugge2,
- Henk Russcher5,
- Annelies Verbon5,
- Judith Gillis6,
- Jürgen Riedl7,
- Eva de Jongh7,
- Jarob Saker1,
- Marion Münster1,
- Imke CA Munnix8,
- Anthonius Dofferhoff8,
- Volkher Scharnhorst9,
- Heidi Ammerlaan9,
- Kathleen Deiteren10,
- Stephan JL Bakker11,
- Lucas Joost van Pelt11,
- Yvette Kluiters-de Hingh3,
- Mathie PG Leers12 and
- André van der Ven13,*
- 1Sysmex Europe GmbH, Hamburg, Germany
- 2Amphia Hospital Breda, the Netherlands
- 3Elisabeth-Tweesteden Hospital Tilburg, the Netherlands
- 4Hospital Papa Giovanni XXIII Bergamo, Italy
- 5Erasmus MC, University Medical Center, Rotterdam, the Netherlands
- 6Leiden University Medical Center, the Netherlands
- 7Albert Schweitzer Hospital Dordrecht, the Netherlands
- 8Canisius Wilhelmina Hospital Nijmegen, the Netherlands
- 9Catharina Hospital Eindhoven, the Netherlands
- 10University Hospital Antwerp, Antwerp, Belgium
- 11University Medical Center Groningen, University of Groningen, Groningen, the Netherlands
- 12Zuyderland Medical Center, Sittard-Geleen, the Netherlands
- 13Radboud University Medical Center, Nijmegen, the Netherlands
- ↵*Corresponding author:
André van der Ven, MD PhD, DTMH, Infectious Disease Specialist, Professor International Health, Radboudumc, Department of Internal Medicine, Radboud Center for Infectious Diseases, PO Box 9101, 6500HB Nijmegen, the Netherlands, Email: andre.vanderven{at}radboudumc.nl, Tel: +31652626633, Fax: +31243541734
Posted September 28, 2020.
A novel haemocytometric COVID-19 prognostic score developed and validated in an observational multicentre European hospital-based study
